Menu

• Ask a Health Expert about CSF PROTEIN INCREASED
• Post Your Side Effect related to CSF PROTEIN INCREASED
• CSF PROTEIN INCREASED and FDA Warnings
• CSF PROTEIN INCREASED in Patients Wiki
• Report CSF PROTEIN INCREASED in Drug Side Effect Survey

CSF PROTEIN INCREASED side effect

What is CSF PROTEIN INCREASED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Pevaryl Side Effects Report #5630718-4
Physician from DENMARK reported PEVARYL problem on Feb 11, 2008. Female patient, weighting 123.5 lb, was diagnosed with vulvovaginal mycotic infection and was treated with PEVARYL. After drug was administered, patient experienced the following problems/side effects: csf protein increased, csf white blood cell count positive, mononeuritis, paraesthesia, peripheral coldness, rash, sensory loss, thrombocythaemia, . PEVARYL dosage: unknown. Patient was hospitalized. Patient recovered.

Natalizumab Side Effects Report #5577888-4
NATALIZUMAB problem was reported by a Health Professional from UNITED STATES on Dec 19, 2007. Female patient, 63 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: csf protein increased, fatigue, multiple sclerosis relapse, nervous system disorder, neuromyelitis optica, pneumonia, quadriplegia, spinal cord disorder, urinary tract infection, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with LEVOXYL, BONIVA, AMBIEN, NOVANTRONE. Patient was hospitalized. Patient died on 07/01/2007.

Omnipaque Side Effects Report #5420618-7
Physician from UNITED STATES reported OMNIPAQUE problem on Aug 09, 2007. Female patient, 59 years of age, was diagnosed with carotid artery disease and was treated with OMNIPAQUE. After drug was administered, patient experienced the following problems/side effects: csf protein increased, dystonia, gaze palsy, hemiparesis, nervous system disorder, posturing, . OMNIPAQUE dosage: unknown. During the same period patient was treated with FENTANYL, VALIUM, LIDOCAINE, LEVOTHYROXINE, ASPIRIN. Patient was hospitalized. Patient recovered.

Omnipaque Side Effects Report #5757793-0
OMNIPAQUE problem was reported by a Consumer or non-health professional from JAPAN on May 20, 2008. Female patient was diagnosed with spinal myelogram and was treated with OMNIPAQUE. After drug was administered, patient experienced the following problems/side effects: csf protein increased, . OMNIPAQUE dosage: unknown. Patient was hospitalized. Patient recovered.


Octagam Side Effects Report #5378256-0
Consumer or non-health professional from BELGIUM reported OCTAGAM problem on June 06, 2007. Female patient, 54 years of age, was diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy and was treated with OCTAGAM. After drug was administered, patient experienced the following problems/side effects: csf protein increased, electromyogram abnormal, muscle contractions involuntary, nerve conduction studies abnormal, red blood cell sedimentation rate increased, wheelchair user, . OCTAGAM dosage: 400 MG/KG I.V.. Patient recovered.

Naglazyme Side Effects Report #5591022-6
NAGLAZYME problem was reported by a Physician from BRAZIL on Dec 26, 2007. Male patient, child 7 years of age, weighting 32.19 lb, was diagnosed with mucopolysaccharidosis vi and was treated with NAGLAZYME. After drug was administered, patient experienced the following problems/side effects: arthropathy, csf protein increased, disease progression, meningeal disorder, myelopathy, nuclear magnetic resonance imaging brain abnormal, spinal cord compression, . NAGLAZYME dosage: 1.5 ML; QM; INTH; 15 MG; X1; IV. Patient recovered.

Mylotarg Side Effects Report #5593176-4
Consumer or non-health professional from UNITED STATES reported MYLOTARG problem on Jan 15, 2008. Male patient, weighting 196.7 lb, was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: csf protein increased, diarrhoea, guillain-barre syndrome, infection, muscle twitching, pyrexia, rash maculo-papular, . MYLOTARG dosage: 12 MG. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, ALLOPURINOL, CEFTAZIDIME, FLUCONAZOLE, TAZOCIN, VANCOMYCIN. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5601376-X
PROGRAF problem was reported by a Physician from UNITED STATES on Dec 21, 2007. Female patient, 44 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: chronic inflammatory demyelinating polyradiculoneuropathy, csf protein increased, facial palsy, light chain analysis increased, . PROGRAF dosage: 3 MG, BID, ORAL; 1 MG, BID, ORAL. Patient recovered.

Chantix Side Effects Report #5501656-2
Physician from UNITED STATES reported CHANTIX problem on Oct 26, 2007. Female patient, weighting 219.0 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, csf protein increased, feeling abnormal, headache, memory impairment, muscular weakness, paraesthesia, tremor, visual disturbance, . CHANTIX dosage: unknown. Patient was hospitalized. Patient recovered.


Dexamethasone Side Effects Report #5409909-3
DEXAMETHASONE problem was reported by a Health Professional from UNITED KINGDOM on Aug 02, 2007. Female patient, 40 years of age, was diagnosed with hodgkin's disease and was treated with DEXAMETHASONE. After drug was administered, patient experienced the following problems/side effects: csf glucose increased, csf protein increased, febrile neutropenia, malignant neoplasm progression, metastasis, pleocytosis, . DEXAMETHASONE dosage: unknown. During the same period patient was treated with DOXORUBICIN, BLEOMYCIN, CISPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE, ETOPOSIDE, METHOTREXATE, PREDNISONE. Patient was hospitalized. Patient recovered.

Betaseron Side Effects Report #5431744-0
Consumer or non-health professional from UNITED STATES reported BETASERON problem on Aug 22, 2007. Male patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, csf protein increased, dysarthria, dyskinesia, motor dysfunction, tremor, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

Cyclosporine Side Effects Report #5432532-1
CYCLOSPORINE problem was reported by a Health Professional from UNITED STATES on Aug 27, 2007. Male patient, 56 years of age, was diagnosed with renal transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: csf cell count increased, csf protein increased, diarrhoea, electroencephalogram abnormal, grand mal convulsion, intubation, lung infiltration, mechanical ventilation, mental status changes, . CYCLOSPORINE dosage: 100 MG, QD. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, PREDNISONE, DACLIZUMAB. Patient was hospitalized. Patient died on 11/18/2005.

Methotrexate Side Effects Report #5760127-9
Consumer or non-health professional from reported METHOTREXATE problem on May 30, 2008. Male patient, 30 years of age, was diagnosed with prophylaxis, acute lymphocytic leukaemia, evidence based treatment and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: csf immunoglobulin increased, csf protein increased, febrile neutropenia, pneumonia bacterial, radiculopathy, respiratory tract infection, sepsis, urinary incontinence, urinary retention, . METHOTREXATE dosage: unknown. During the same period patient was treated with PREDNISONE, VINCRISTINE, DAUNORUBICIN, CYTARABINE, ELSPAR, HYDROCORTISONE, IMMUNE GLOBULIN INTRAVENOUS. Patient was hospitalized. Patient died.

Velcade Side Effects Report #5786833-8
VELCADE problem was reported by a Physician from JAPAN on June 11, 2008. Female patient, 68 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, csf protein increased, disease progression, dysarthria, dysstasia, encephalitis viral, haemoglobin decreased, haemorrhage, . VELCADE dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with ZOFRAN, LASIX, RABEPRAZOLE, RED BLOOD CELLS, PLATELETS. Patient died on 03/27/2008.


Natalizumab Side Effects Report #5341135-9
Consumer or non-health professional from UNITED STATES reported NATALIZUMAB problem on May 16, 2007. Female patient, 63 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: condition aggravated, csf protein increased, facial paresis, multiple sclerosis, neuromyelitis optica, pneumonia, quadriparesis, urinary tract infection, . NATALIZUMAB dosage: 200 MG; QM; IV. During the same period patient was treated with LEVOXYL, BONIVA, AMBIEN. Patient was hospitalized. Patient recovered.

Carbamazepine Side Effects Report #5305886-4
CARBAMAZEPINE problem was reported by a Health Professional from INDIA on Mar 28, 2007. Female patient, weighting 8.38 lb, was diagnosed with epilepsy and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: arteriovenous malformation, csf protein increased, dysmorphism, foetal anticonvulsant syndrome, haematoma, haemorrhage intracranial, hydrocephalus, hypertelorism of orbit, . CARBAMAZEPINE dosage: 900 MG DAILY, TRANSPLACENTAL. Patient died.

Viraferonpeg Side Effects Report #5616645-7
Physician from FRANCE reported VIRAFERONPEG problem on Jan 25, 2008. Male patient, 54 years of age, was diagnosed with hepatitis c and was treated with VIRAFERONPEG. After drug was administered, patient experienced the following problems/side effects: angiogram abnormal, beta globulin increased, csf protein increased, demyelination, depression, eye oedema, ischaemic neuropathy, nuclear magnetic resonance imaging brain abnormal, optic neuritis retrobulbar, . VIRAFERONPEG dosage: 800 MG MCG; QW; SC; 150 MCG; QW; SC. During the same period patient was treated with REBETOL. Patient was hospitalized and became disabled. Patient recovered.

Escitalopram Side Effects Report #5570061-5
ESCITALOPRAM problem was reported by a Health Professional from FRANCE on Nov 29, 2007. Female patient, 60 years of age, was diagnosed with depression, anxiety and was treated with ESCITALOPRAM. After drug was administered, patient experienced the following problems/side effects: agitation, confusional state, csf protein increased, dyskinesia, fall, gait disturbance, grand mal convulsion, hallucination, . ESCITALOPRAM dosage: unknown. During the same period patient was treated with NOCTRAN, MEPRONIZINE, ZOLPIDEM, ZOCOR, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Zometa Side Effects Report #5524930-2
Physician from SPAIN reported ZOMETA problem on Nov 16, 2007. Male patient was diagnosed with prostate cancer and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, amnesia, csf protein increased, dementia, muscle contractions involuntary, . ZOMETA dosage: 4 MG, QMO. During the same period patient was treated with PAMIDRONATE DI. Patient was hospitalized. Patient recovered.


Zometa Side Effects Report #5526219-4
ZOMETA problem was reported by a Physician from SPAIN on Nov 16, 2007. Male patient was diagnosed with prostate cancer and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, amnesia, csf protein increased, dementia, muscle contractions involuntary, . ZOMETA dosage: 4 MG, QMO. During the same period patient was treated with PAMIDRONATE DI. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5449145-8
Consumer or non-health professional from reported CYCLOPHOSPHAMIDE problem on Sept 04, 2007. Male patient, 51 years of age, was diagnosed with b-cell lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: areflexia, asthenia, csf protein increased, dysphagia, guillain-barre syndrome, lymphocyte count decreased, paraesthesia, pyrexia, quadriparesis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, METHYLPREDNISOLONE, RITUXIMAB. Patient was hospitalized. Patient recovered.

Vincristine Side Effects Report #5451829-2
VINCRISTINE problem was reported by a Physician from ITALY on Aug 31, 2007. Male patient, 51 years of age, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: bedridden, condition aggravated, csf protein increased, dysphagia, guillain-barre syndrome, lymphocyte count decreased, white blood cell count decreased, . VINCRISTINE dosage: (1.4 MG/M2). During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, METHYLPREDNISOLONE, RITUXIMAB. Patient recovered.

Fortum Side Effects Report #5776935-4
Consumer or non-health professional from FRANCE reported FORTUM problem on June 09, 2008. Female patient, 85 years of age, was treated with FORTUM. After drug was administered, patient experienced the following problems/side effects: amnesia, confusional state, csf protein increased, disorientation, incoherent, meningitis aseptic, meningitis bacterial, speech disorder, . FORTUM dosage: unknown. During the same period patient was treated with SOTALEX, LERCAN, ADANCOR, ASPIRIN, DESLORATADINE, MOPRAL, BACTRIM, TOPALGIC. Patient was hospitalized. Patient recovered.

Azathioprine Side Effects Report #5730588-X
AZATHIOPRINE problem was reported by a Physician from AUSTRALIA on Apr 18, 2008. Male patient, 64 years of age, was diagnosed with immunosuppression and was treated with AZATHIOPRINE. After drug was administered, patient experienced the following problems/side effects: aspiration, asthenia, csf protein increased, dysphagia, dysphonia, facial paresis, head and neck cancer, renal impairment, squamous cell carcinoma, . AZATHIOPRINE dosage: 137.5 MG; DAILY. During the same period patient was treated with PREDNISOLONE. Patient recovered.

Geodon Side Effects Report #5693842-6
Physician from UNITED STATES reported GEODON problem on Mar 22, 2008. Male patient, weighting 175.0 lb, was diagnosed with agitation, cerebrovascular accident, hypertensive encephalopathy and was treated with GEODON. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood creatinine increased, csf protein increased, haematocrit decreased, neuroleptic malignant syndrome, pyrexia, sepsis, . GEODON dosage: unknown. During the same period patient was treated with ZYPREXA, ANTIHYPERTENSIVES, ATIVAN, COLACE, DEPAKOTE, ASPIRIN. Patient recovered.

Velcade Side Effects Report #5714334-1
VELCADE problem was reported by a Physician from JAPAN on Apr 09, 2008. Female patient, 68 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, cardiomegaly, csf protein increased, disease progression, dysarthria, dysstasia, haemorrhage, hyperviscosity syndrome, . VELCADE dosage: 1.30 MGM2, INTRAVENOUS. Patient died on 03/27/2008.

Valsartan Side Effects Report #5353430-8
Physician from JAPAN reported VALSARTAN AND HYDROCHLOROTHIAZIDE problem on June 01, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with VALSARTAN AND HYDROCHLOROTHIAZIDE. After drug was administered, patient experienced the following problems/side effects: choroidal detachment, csf cell count abnormal, csf protein increased, diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, ocular discomfort, optic nerve disorder, . VALSARTAN AND HYDROCHLOROTHIAZIDE dosage: 40 MG/6.25 MG. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

Simvastatin Side Effects Report #5376168-X
SIMVASTATIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 14, 2007. Male patient, 58 years of age, was diagnosed with hypercholesterolaemia and was treated with SIMVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood creatine increased, blood urea increased, csf protein increased, dyspnoea, eosinophilia, guillain-barre syndrome, haemoglobin decreased, hyponatraemia, international normalised ratio increased, . SIMVASTATIN dosage: unknown. During the same period patient was treated with PRAVASTATIN, AMLODIPINE, BISOPROLOL FUMARATE, RAMIPRIL, SPIRONOLACTONE, WARFARIN. Patient was hospitalized. Patient recovered.

Valsartan Side Effects Report #5317464-1
Physician from JAPAN reported VALSARTAN AND HYDROCHLOROTHIAZIDE problem on Apr 24, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with VALSARTAN AND HYDROCHLOROTHIAZIDE. After drug was administered, patient experienced the following problems/side effects: choroidal detachment, csf cell count abnormal, csf protein increased, diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, ocular discomfort, optic nerve disorder, . VALSARTAN AND HYDROCHLOROTHIAZIDE dosage: 40 MG/6.25 MG. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

Lioresal Side Effects Report #5296105-6
LIORESAL problem was reported by a Health Professional from AUSTRIA on Mar 28, 2007. Male patient was diagnosed with muscle spasticity and was treated with LIORESAL. After drug was administered, patient experienced the following problems/side effects: bone marrow oedema, brain oedema, csf protein increased, dystonia, eaton-lambert syndrome, fibrosis, hypotonia, implant site hypersensitivity, . LIORESAL dosage: unknown. Patient was hospitalized. Patient recovered.

Vincristine Side Effects Report #5297346-4
Health Professional from AUSTRALIA reported VINCRISTINE problem on Mar 26, 2007. Female patient, 26 years of age, was diagnosed with acute lymphocytic leukaemia, acute leukaemia and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: acute lymphocytic leukaemia recurrent, areflexia, csf protein increased, faecal incontinence, loss of proprioception, muscular weakness, myelopathy, nuclear magnetic resonance imaging abnormal, osteomyelitis, . VINCRISTINE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, CYTARABINE, CYCLOPHOSPHAMIDE, MERCAPTOPURINE. Patient died.